Ignite Creation Date:
2025-12-24 @ 3:15 PM
Ignite Modification Date:
2025-12-27 @ 9:51 PM
Study NCT ID:
NCT03405792
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-28
First Post:
2018-01-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)
Sponsor:
University of Florida
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-02-23
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-12
Completion Date Type:
ESTIMATED
First Submit Date:
2018-01-12
First Submit QC Date:
None
Study First Post Date:
2018-01-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-11-08
Results First Submit QC Date:
None
Results First Post Date:
2024-04-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-10
Last Update Post Date:
2025-10-28
Last Update Post Date Type:
ESTIMATED